Overall survival (OS) in advanced non-small cell lung cancer (aNSCLC) patients treated with frontline chemotherapy or immunotherapy by comorbidity: A real-world data (RWD) collaboration

2020

Rivera DR, Lasiter L, Christian J, Enewold L, Espirito JL, Hansen E, Henk HJ, Kushi LH, Lane D, Natanzon Y, Pe Benito R, Rasmussen E, Robert NJ, Stewart M, Sweetnam C, Tymejczyk O, Valice E, Wagner J, Zander A, Allen J